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properties for Thl cells and therefore play an important place in the active suppression of oral tolerance and IgE response. The gut-associated lymphoid tissue (GALT) also contributes to protect the host from reacting to ingested antigens. T cells in these organs secrete IL-4 as a primary T-cell growth factor whereas those T cells in lymph nodes of the rest of the organism secrete IL-2 (4). When large doses of antigen enter the intestinal mucosa, Th2 responses are induced but anergy and/or deletion of CD8+ T cells takes place suppressing these cells (16) . The importance of this phenomenon resides in the fact that oral tolerance has been used to treat autoimmune diseases in animal models and are present induction of oral tolerance to fed proteins is being tested in several human diseases, such as multiple sclerosis, rheumatoid arthritis, type I diabetes and uveitis (27) .
FOOD ALLERGY
Hypersensitivity to food or food components produces a mixture of digestive and extra-digestive clinical symptoms. A genetic predisposition is important and genes involved in IgE production and mast cell degranulation appears to be involved. Unfortunately it is a relatively common condition and approximately 6% of asthmatics and 6% of atopic dermatitis patients have a documented single or multiple food allergy (20) . Recent studies have found that children with atopic eczema with food allergy have intestinal inflammation. When children with cow's milk allergy are challenged with cow's milk, eosinophil cationic protein, TNFa and a-1 antitrypsin are significantly increased in the faeces (15) . Up till now the only treatment was by careful elimination of the offending food. More recently, probiotics, such as lactobacillus GG have shown to promote a local IgA response and improve permeability defects and by these mechanisms be useful in the treatment of atopic dermatitis and food allergy (14) .
HELICOBACTER PYLORI GASTRITIS
The extent and severity of the inflammatory response depends on the genetic diversity of the bacteria on the one hand and on the genetic constitution of the host on the other. For example, some strains of H. pylori have a 40 kb segment that includes the cytotoxin-associated gene (cagA) (3), a virulence marker associated with duodenal ulcer and gastric cancer. Other strains have a homologue of the Bordetella pertussis toxin, a protein that is secreted and induces IL-8 in gastric epithelial cells (26) . This cytokine is one the most important factors in determining the neutrophil infiltration a hallmark of the gastritis induced by H. pylori. Only few studies have been directed to understand the host response in the regulation of the inflammatory response in the stomach, in spite that it is known that interleukin-(IL-113) and its natural specific inhibitor, the interleukin-1 receptor antagonist (ILIra) are involved in maintaining the gastric mucosal integrity. Recent reports have indicated that allele 2 of the biallelic TaqI polymorphism of the IL-113 gene and allele 2 of the pentaallelic IL-1 ra gene are associated with an increased production of their gene products in healthy individuals.
Since the relative balance between the production of these two cytokines are important in modulating the inflammatory response on gastrointestinal mucosa we have recently studied whether these polymorphic genes are involved in the susceptibility to peptic ulcer disease. We studied 159 unrelated this disease. Patients with duodenal ulcer and repeated bleedings were more often found to be non-carriers of the ILIra allele 2 than controls (p=0.045, OR=2.71). Furthermore, bleeding duodenal ulcer patients non carriers of IL-1B allele 2 were often found to be carriers of allele 2 of the IL-lra gene (p<0.0001), whereas this was not the case in both bleeding gastric ulcer patients, and in controls (9) .
CELIAC DISEASE
Occasionally, peptides of a wheat-containing diet produce inflammation in the small intestine of certain individuals, such is the case of celiac disease or gluten-sensitive enteropathy. A working hypothesis to understand the pathogenesis of celiac disease is that peptides produced by the ingestion of gluten (gliadin and related prolamines) are bound to HLAclass II molecules in the late endosomal or lysosomal compartment of enterocytes during uptake across the small intestinal epithelium (29) . This is an early event characterized by HLA-DR overexpression in the villus enterocytes (13) .
Trimmed peptides are, possibly mediated by dendritic cells or monocytes/macrophages in the lamina propria, presented to antigen specific CD4+ T cells (5) . This elicits a predominantly Thl pattern of cytokine production by the celiac disease associated HLA-DQ restricted T cell clones. Both HLA-DQ2 and DQ8 restricted gliadin-specific T cells have been shown to produce IFN--y which is involved in the damage to the epithelial cells of the small intestine since the histological changes can be blocked by anti-IFN--y antibodies in vitro (18) . TNFa, also produced by several clones may in conjunction with IFN--y have a toxic effect or like IFN--y increase class II expression on the surface of epithelial cells. In the lamina propria this leads to increased expression of adhesion molecules such as ICAM-1 on T lymphocytes and macrophages (22, 24, 25) . During this process autoreactive T cells proliferate, creating a situation which is very similar to the process that takes place in other autoimmune diseases. Occasionally, this inflammatory destruction of the small intestinal integrity initiated by gluten-peptides goes further and develops into a proper autoimmune disease requiring the use of immunosuppressive drugs in addition to a gluten-free diet (17) . The genetic basis of the inflammatory response in celiac disease resides in several chromosomes. A primary association exists with the combination of alleles DQA1*0501-DQB1*02 at the HLA-DQ locus. These alleles are arranged either in cis or trans configuration, whereas a minority of patients carries the HLA-DR4 associated DQB1*0302 (DQ8 determined serologically) (23) . It is possible that the variants of the much less polymorphic MHC class III genes play a modulatory role in the control of inflammation. For example, although very strong linkage disequilibrium has been demonstrated between genes of the disease-associated HLA-B8-DR3-DQ2 extended haplotype, varying degrees of recombination on less well-conserved haplotypes exist. It may thus be the combination of alleles at the primary disease associated DQ loci and at other non-HLA genes that determine the clinical outcome of the disease (7).
INFLAMMATORY BOWEL DISEASE
Other mechanisms exist in the small and large intestine that initiate and maintain a chronic inflammatory state such as is the case in chronic inflammatory bowel diseases (ulcerative colitis and Crohn's disease). One recent and interesting possibility is that these patients have lost the tolerance against their own bacterial flora. Recent studies have shown that faecal extracts of both homologous and heterologous persons stimulate lamina propria lymphocytes of patients with inflammatory bowel disease to produce pro-inflammatory cytokines whereas lymphocytes from control persons only react against heterologous faecal extracts (8). These studies need confirmation, however, whatever the cause, it is clear that these patients have an abnormal regulation of the inflammatory response. A mucosal imbalance exists between interleukin-1 and its receptor antagonist in favour of IL-113 (6) . Data has also shown a significant production of pro-inflammatory cytokines (IL-113, 11-6 and TNFa), both at the mRNA in the intestinal mucosa, detected by the polymerase chain reaction (10) and by the ELISA-spot technique (TNFa) (12) . Lamina propria mononuclear cells of patients with inflammatory bowel disease that produce increased amount of IL-113 and TNFa have an early acute relapse (18) . Functionally active NFkB has been found in nuclear extracts of neutrophils of patients with inflammatory bowel disease (19) . On the other hand, it is possible that some of these patients have a defect in the inhibition of the pro-inflammatory response. Preliminary evidence suggests that in some patients IL-4 cannot down regulate monocytes of active IBD patients (11, 19, 21, 28) .
In summary, the abnormal immune response in the human gut is predominantly a Th I -like inflammatory response.
Bacteria, peptides, and possibly the bacterial flora and some viruses can elicit this. We have documented in this review in a concise manner some of these mechanisms. The recent findings in the pathogenesis of the intestinal inflammatory response will probably alter the therapy of the future. The most recent therapeutic modalities are pointed towards the control of different cytokines involved in the inflammatory process, the inhibition of adhesion molecules of macrophages and neutrophils, or the development of cytokines that regulate inflammation (1). Also under review is the possible application of the interleukin-1 receptor antagonist, although its short half-life and the need to use very high doses to reach therapeutic levels undermine its efficacy (2).
INTRODUCTION
The major end-products from anaerobic breakdown of polysaccarides by intestinal microorganisms are short-chain fatty acids (SCFA), mainly acetate, propionate and butyrate. The major fermentation substrates include cellulose, hemicellulose and pectin, substrates that are not digested by host enzymes. Considerable amounts of SCFA can be produced in the large intestine. Calculations of SCFA production in dog and in man with a small rather simple hind gut accounts for about 7% of energy maintenance requirement of these species (19, 100) . In animals with a voluminous fermentation chamber in the large intestine, maintenance energy derived from SCFA comes up to 80% (5, 11, 100) . This may illustrate that SCFA produced in the large intestine could be an important fuel for the overall energy metabolism in some animals. In addition, SCFA are of major significance for a number of further processes, especially in the hind gut mucosa. Excellent reviews on physiological and clinical aspects of SCFA in the large intestine had been published recently (6, 20, 48, 63, 73, 75,
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